user

Once-daily dosing of insulin detemir is associated with lower risk of hypoglycaemia at similar levels of HbA1c compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus

被引：0
|
作者：
Shaw, J. E. [1 ]
Larsen, J. [2 ]
Pedersen, C. B. [2 ]
Tang-Fui, S. [3 ]
机构：
[1] Int Diabet Inst, Dept Med, Melbourne, Vic, Australia
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
[3] Endocrinol Diabet & Specialist Ctr, Melbourne, Vic, Australia
来源：
DIABETOLOGIA | 2008年 / 51卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
971
引用
收藏
页码：S391 / S391
页数：1
相关论文
共 50 条
  • [1] Treatment with insulin detemir once daily is associated with lower risk of hypoglycemia at similar levels of HbA1c compared to once-daily NPH insulin in subjects with type 1 diabetes mellitus
    Shaw, Jonathan E.
    Larsen, Jens
    Pedersen, Claus B.
    Tang-Fui, Serge
    [J]. DIABETES, 2008, 57 : A595 - A595
  • [2] Once daily dosing with insulin detemir offers advantages compared to NPH insulin in subjects with type 1 diabetes
    Russel-Jones, D
    Bolinder, J
    Simpson, R
    Stades, A
    Stender, A
    Hylleberg, B
    Draeger, E
    [J]. DIABETES, 2003, 52 : A132 - A132
  • [3] Detemir as a once-daily basal insulin in type 2 diabetes
    Nelson, Scott E.
    [J]. CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2011, 3 : 27 - 37
  • [4] Comparison of Once-daily versus Twice-daily Injection of Insulin Detemir in Children with Type 1 Diabetes Mellitus
    Setoodeh, Aria
    Rabbani, Ali
    Sayarifard, Fatemeh
    Haghshenas, Zahra
    Sayarifard, Azadeh
    Rostami, Parastoo
    Abbasi, Farzaneh
    Bayat, Mohadeseh
    Amini, Sima
    Tavakolizadeh, Reza
    [J]. IRANIAN JOURNAL OF PEDIATRICS, 2022, 32 (06)
  • [5] Study of Once-Daily Levemir (SOLVE™): Weight Changes Associated With the Initiation of Once-Daily Insulin Detemir in Chinese Patients With Type 2 Diabetes
    Pan, Changyu
    Ji, Qiuhe
    Li, Yanbing
    [J]. DIABETES, 2012, 61 : A612 - A612
  • [6] Once-daily insulin detemir in cystic fibrosis related diabetes (CFRD)
    Hameed, Shihab
    Morton, John R.
    Jaffe, Adam
    Field, Penny I.
    Belessis, Yvonne
    Yoong, Terence
    Katz, Tamarah
    Woodhead, Helen J.
    Walker, Jan L.
    Campbell, Thomas A.
    Verge, Charles F.
    [J]. HORMONE RESEARCH, 2009, 72 : 160 - 161
  • [7] Lower and more predictable fasting blood glucose and reduced risk of nocturnal hypoglycaemia with once daily insulin detemir versus NPH in subjects with Type 1 diabetes
    Russell-Jones, D
    Bolinder, J
    Simpson, R
    [J]. DIABETOLOGIA, 2002, 45 : A51 - A51
  • [8] Study of once-daily Levemir (SOLVE™) 3: safety of once-daily insulin detemir in patients with type 2 diabetes treated with oral antidiabetic therapy
    Ross, S. A.
    Dzida, G.
    Ligthelm, R. J.
    [J]. DIABETOLOGIA, 2011, 54 : S422 - S423
  • [9] Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes
    Philis-Tsimikas, Athena
    Charpentier, Guillaume
    Clauson, Per
    Ravn, Gabriela Martinez
    Roberts, Victor Lawrence
    Thorsteinsson, Birger
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (10) : 1569 - 1581
  • [10] Study of Once-Daily Levemir (SOLVE™): Safety and Efficacy of Once-Daily Insulin Detemir in Routine Clinical Practice in Chinese Patients With Type 2 Diabetes
    Pan, Changyu
    Lu, Juming
    Gao, Zhengnan
    [J]. DIABETES, 2012, 61 : A616 - A616
12345